Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-centre, Prospective, Non-interventional Study Investigating the Effectiveness of Once-weekly Subcutaneous Semaglutide in a Real World Adult Population With Type 2 Diabetes

Next Previous
Search
Trial Profile

A Multi-centre, Prospective, Non-interventional Study Investigating the Effectiveness of Once-weekly Subcutaneous Semaglutide in a Real World Adult Population With Type 2 Diabetes

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Semaglutide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SURE UK
  • Sponsors Novo Nordisk

    • Most Recent Events

    • 06 Oct 2023 Results of pooled post hoc analysis from SURE programme: Canada, Denmark/Sweden, France, Germany, Italy, the Netherlands, Switzerland, Spain and the UK psafety of once-weekly (OW) semaglutide prescribed to adults with type 2 diabetes (T2D) in routine clinical practice presented at the 59th Annual Meeting of the European Association for the Study of Diabetes.
    • 06 Oct 2020 Status changed from active, no longer recruiting to completed.
    • 14 Jul 2020 Planned End Date changed from 28 Aug 2020 to 11 Sep 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top